Conference Reports for NATAP

AASLD The Liver Meeting November Fri, Nov 10, 2023 - Mon, Nov 14, 2023   Back

RESMETIROM IMPROVES THE ATHEROGENIC LIPID/LIPOPROTEIN PROFILE IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS: 52-WEEK DATA FROM THE PHASE 3 MAESTRO-NASH TRIAL       AASLD 2023 nov 10-14   https://www.aasld.org/the-liver-meeting